NCT07166302View on ClinicalTrials.gov

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Direct Acting Anticoagulant Adverse ReactionNeedle InjuryEMGPeripheral NeuropathiesMononeuropathiesPolyneuropathiesNeuromuscular Diseases (NMD)
Trial Locations (2)

62500

RECRUITING

University Hospital Brno, Brno

RECRUITING

University hospital Brno, Brno

All Listed Sponsors
collaborator

University Hospital Brno

UNKNOWN

lead

Masaryk University

OTHER

NCT07166302 - Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy | Biotech Hunter | Biotech Hunter